Skip to content

Effectiveness of Malakudaara Mezhugu in the management of Kattu Mantham (Functional Constipation)

An open single arm, single centric phase II clinical trial to evaluate the effectiveness of Malakudaara Mezhugu in the management of Kattu Mantham (Functional Constipation) in children - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055098
Enrollment
30
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K590- Constipation

Interventions

Intervention1: Malakudaara Mezhugu: Dosage : 1 Year- 200mg 2 Year- 400 mg 3 year- 500 mg with milk in the night after food Route of administration: Oral Duration: 7 days Control Intervention1: Nil: N

Sponsors

Ayothidoss Pandithar Hospital, Ayothidoss Pandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with minimum two of the following clinical symptoms for atleast three month (Based on Rome IV criteria for Functional Constipation) 1) Straining during more than one-fourth (25%) of defecations 2) Lumpy or hard stools (Bristol Stool Form Scale 1 or 2) more than one-fourth (25%) of defecations 3) Sensation of incomplete evacuation more than one-fourth (25%) of defecations 4) Sensation of anorectal obstruction/blockage more than one-fourth (25%) of defecations 5) Manual maneuvers to facilitate more than one-fourth (25%) of defecations (such as digital evacuation, or support of the pelvic floor) 6) Fewer than 3 Spontaneous Bowel Movements per week 7) Patient’s informant / Parent willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Intolerance to the drug and development of adverse reactions such as nausea, vomiting, abdominal discomfort during trial period. 2) Poor patient compliance & defaulters. 3) Patient turned unwilling to continue in the course of clinical trial. 4) Aggravation of symptoms.

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed using Bristol Stool Scale in children with Functional Constipation.Timepoint: 7 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026